1. AF.35 ELIMINATION DIETS AND SELF-REPORTED FOOD INTOLERANCES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (September 2021) Authors: Guida, L.; Di Giorgio, F.M.; Busacca, A.; Carrozza, L.; Ciminnisi, S.; Almasio, P.L.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.38 SHORT BOWEL SYNDROME IN ITALY, YET UNDERESTIMATED AND IN NEED OF INCREASED AWARENESS: PRELIMINARY REPORT FROM AN AIGO SURVEY. (September 2021) Authors: Cappello, M.; Carrozza, L.; Busacca, A.; Guida, L.; Soncini, M.; Monica, F.; Milazzo, G. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY. (September 2021) Authors: Busacca, A.; Sinagra, E.; Guida, L.; Carrozza, L.; Maida, M.; Battaglia, S.; Celsa, C.; Cammà, C.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Busacca, A.; Fries, W.; Viola, A.; Costantino, G.; Magnano, A.; Vinci, E.; Ferracane, C.; Privitera, A.C.; Piccillo, G.; Belluardo, N.; Giangreco, E.; Romano, C.; Citrano, M.; Graziano, F.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Scrivo, B. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AF.60 A PILOT STUDY ON THE USE OF USTEKINUMAB IN REFRACTORY PERIANAL CROHN'S DISEASE. (September 2021) Authors: Crispino, F.; Brinch, D.; Busacca, A.; Carrozza, L.; Cocorullo, G.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?. (March 2021) Authors: Celsa, C.; Cabibbo, G.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Stornello, C.; Giuffrida, P.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.02.3 SEQUENTIAL THERAPY IN THE MANAGEMENT OF MODERATE-TOSEVERE ULCERATIVE COLITIS: MARKOVIAN MODELS TO GUIDE TREATMENT CHOICES. (May 2022) Authors: Busacca, A.; Sinagra, E.; Battaglia, S.; Celsa, C.; Carrozza, L.; Muscarella, S.; Crispino, F.; Brinch, D.; Guida, L.; Camma, C.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.04.3 FIRST-LINE IMMUNE CHECKPOINT INHIBITOR-BASED SEQUENTIAL THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A RATIONALE FOR FUTURE TRIALS. (September 2021) Authors: Cabibbo, G.; Celsa, C.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Petta, S.; Calvaruso, V.; Di Marco, V.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.07.2 ENDOSCOPIC RESECTION OF VISIBLE PRECANCEROUS LESIONS IN PATIENTS WITH COLONIC INFLAMMATORY BOWEL DISEASE. (March 2023) Authors: Busacca, A.; De Sire, R.; Capogreco, A.; Dal Buono, A.; Gabbiadini, R.; Loy, L.; Finati, E.; Spadaccini, M.; Maselli, R.; Hassan, C.; Repici, A.; Armuzzi, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.09.4 PREVALENCE OF NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) IN INFLAMMATORY BOWEL DISEASE: THE ROLE OF METABOLIC FACTORS, INTESTINAL INFLAMMATION AND GENETIC PHENOTYPE. (September 2021) Authors: Scrivo, B.; Crispino, F.; Celsa, C.; Sapia, A.; Busacca, A.; Pipitone, R.M.; Grimaudo, S.; Cammà, C.; Petta, S.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗